Enterprise model
The SAIR Enterprise business, technology and commercial model as documented.
Illustrative operational scenarios; historical laboratory evidence is identified separately. No live surveillance, integrations or AI models are connected.
GermQ proposed B2B/B2G SaaS positioning: Standard for institutional surveillance, Premium for connected intelligence, Enterprise for multi-institution and government coordination. Source frameworks below remain attributed to the SAIR Enterprise deck; technology is planned, costs and revenue are projections, and named entities are not claimed as active GermQ partners or customers.
Global digital health market
$233.5b
2022 size, ~15% CAGR to 2032 (Global Market Insights)
International healthcare analytics
$32.7b
Expected market value by 2030
Local digital health market
$2.01b
Saudi Arabia 2023, reaching $6.8b by 2030
Local health budget
SAR 214b
Health and social development, 28 entities (MoF 2024)
Business model canvas
Key partners
- Public health authorities
- Healthcare institutions
- Government and private hospitals and PHCs
- Regulatory affairs and environmental agencies
- Pharmaceutical and consultation companies
- Research centres and academia
- Healthcare professionals and providers
- Developers and health-tech companies
Key activities
- Platform development
- Data integration and centralisation
- Research and predictions
- Digital dashboard operation
- AI-driven analysis of AMR
Key resources
- Technology infrastructure
- Data analysts and AI team
- Human resources
- Laboratory information
- Protocols and guidelines
- Partnerships and alliances
- Passive and active datasets
Value propositions
- An engaging community working to eliminate AMR
- A cutting-edge analytic tool that can inform decisions
- An integrated, centralised system that optimises care and prevention
- A rapid instrument drawing accurate conclusions for diagnostics and treatment
- Improving and standardising healthcare practice
Customer relationships
- Built-in integrated system
- Top-notch customer service
- Automated support
- Live chat
- Technological ecosystem
- Healthcare communities
- Outreach teams and peer-to-peer interaction
Channels
- Digital channels and portals
- Open AI platform
- Healthcare professionals, researchers and networks
- Vendors
- Conferences and symposiums
Customer segments
- Public health authorities
- Healthcare institutions
- Hospitals and primary healthcare centres
- Regulatory and environmental agencies
- Pharmaceutical and consultation companies
- Research centres and academia
- Developers and health-tech companies
Cost structure
- Research and development
- Logistics and event management
- Administrative costs
- Marketing
Revenue streams
- Subscription fees (SaaS)
- Data analytics services (B2B)
- Product sale (one-time)
- Consultation and telehealth services
- API integrations
- Health investments
- Licensing fees
- Grants and sponsorships
Value proposition canvas
Customer jobs
- Accessing personalised healthcare recommendations and predictions
- Utilising advanced medical data analysis
- Leveraging medical records and real-time patient data
- Integrating AI into healthcare practice
Customer pains
- Limited access to advanced medical data
- Commitment towards regulations remains lax
- Shortage of funding for research studies
- Lack of epidemiological intelligence
- Scarcity of a skilled workforce
Expected gains
- Favourable patient outcomes through a holistic approach
- Healthcare revolutionisation through AI integration
- Diagnosis and treatment optimisation
- Data analysis for actionable insight and regulatory decision support
- Streamlined operations for hospitals, PHCs and healthcare facilities
Pain relievers
- Machine-learning algorithms for integrated, centralised AMR data
- Natural-language processing for efficient predictions and decisions
- Cutting-edge analysis of medical records and real-time patient data
- Collaboration with institutions and facilities to implement the AI platform
- E-health tooling for regulators and providers with standardised guidelines
- Reduction of time-consuming processes
Products and services
- Centralised AI platform
- Integrated concentric dashboard for analysis and control
- Social and research features
- E-application for easy communication
- Software analysis and standardised guidelines
Historical SAIR value proposition
Available dataset
An excellent surveillance system linking each organism with its resistance patterns to support policymakers.
Research development
Novel AMR studies with ID centres, providing training opportunities for healthcare providers.
Network
A team of more than 500 healthcare providers worldwide participating to eliminate this silent pandemic.
Consultation
Telemedicine and virtual health with predictions based on clinical history and societal resistance patterns; dispensing linked to the platform as a registry.
Operation
Registering patients with AMR at primary healthcare centres and hospitals, especially in rural areas.
Rapid analytic tests
Remote testing and culturing for affected people and poultry animals for surveillance and diagnostics.
SWOT analysis
Strengths
An integrated project with innovative AI solutions and global and local partnerships across health, education, environment and regulatory affairs.
Weaknesses
Funding and logistics may arrive late, alongside challenges with statistical data.
Opportunities
Educating community members of various backgrounds and activating basic and clinical research, with solicited consultation and assessment.
Threats
Population increase means increased demand; clinician and non-clinician collaboration may cease, requiring fast support.
Approach summary (AEIEI)
- 1Analyse. Analysis through data mining and artificial intelligence to make robust decisions.
- 2Evadite. Expanding the horizons of knowledge so the burden of disease falls once the health system is strengthened.
- 3Improve & economise. Evidence-based research standardises medical practice, building rapid, efficient diagnosis that economises resources.
- 4Intervene. Zero tolerance towards AMR, elucidated by the economic case and a risk-mitigation strategy.
User personas
Personas are illustrative profiles used in the enterprise documentation.
Senior AMR researcher
KAIMRC
- Location:
- Riyadh, Saudi Arabia
- Education:
- PhD in infectious diseases and public health
- Experience:
- 10 years in AMR research, stewardship and global policy advocacy
- Income:
- $112,000 / year
Senior policy advisor
Saudi Public Health Authority
- Location:
- Riyadh, Saudi Arabia
- Education:
- Master of public policy, MPH
- Experience:
- 10 years on local health policies with an AMR focus
- Income:
- $80,000 / year
Project manager
Health-tech startup
- Location:
- Riyadh, Saudi Arabia (works across countries remotely)
- Education:
- BSc computer science, MSc health informatics
- Experience:
- 7 years leading health software development
- Income:
- Chose not to reveal
Senior consultant, infectious diseases
Tertiary hospital
- Location:
- Cairo, Egypt
- Education:
- MD in infectious diseases
- Experience:
- 15 years in healthcare, specialising in ID and antibiotic stewardship
- Income:
- $96,000 / year
Senior executive and angel investor
Health and technology holdings
- Location:
- Dubai, UAE
- Education:
- MBA, Georgetown University
- Experience:
- 15 years in leadership and investment
- Income:
- $300,000 / year
Board member, procurement
NUPCO
- Location:
- Riyadh, Saudi Arabia
- Education:
- BSc supply chain management, MBA in SCM
- Experience:
- 15+ years in pharmaceutical procurement and supply chain
- Income:
- $140,000 / year
Regulatory affairs specialist
SFDA
- Location:
- Riyadh, Saudi Arabia
- Education:
- Executive master in drug regulatory affairs, King Saud University
- Experience:
- 5 years in regulatory affairs
- Income:
- $70,000 / year
Customer journey map
Actions
- Attend a specialised event or webinar
- Read an article, white paper, policy brief or report
- Review previous campaigns, infographics and videos
Pain points
- Limited knowledge of digital tools for AMR
- Concerns about cost and ROI
- Sharing of data from the government sector
Solutions
- Case studies and success stories
- Introductory webinars and posts
Actions
- Research the project
- Compare features and pricing
- Download a case study or white paper
- Schedule a illustrative
Pain points
- Uncertainty about integration with existing systems such as EHRs
- Empowerment issues from the sectors
Solutions
- Highlight EHR integration and regulatory compliance
- Testimonials and endorsements
Actions
- Request a proposal or quotation
- Agree to pilot the platform
- Finalise purchase and contracts
- Complete onboarding and technical setup
Pain points
- Concerns about upfront costs or pilot ROI
- Resistance from some organisations to adopt
Solutions
- Pilot programmes and flexible pricing
- Onboarding support and training
Actions
- Actively use the platform and renew the subscription
- Attend advanced training
- Share feedback and referrals
Pain points
- Need for new features as the organisation evolves
- Potential user fatigue
Solutions
- Ongoing feature updates and custom analytics reports
- Loyalty programme and multi-year discounts
Actions
- Share testimonials and speak at AMR events
- Refer providers, agencies and pharma companies
- Publish joint research and case studies
Pain points
- Maintaining engagement long term
- Continuous updates and regulations from stakeholders
Solutions
- Referral and co-branded marketing incentives
- Involve customers in product development
Planned technology features
Front-end advancement
Minimal CSS, reduced external HTTP requests and adaptive web design for a user-centric experience.
Back-end development
Python for predictive analysis and decision support, with data prepared to best practice.
Authentication and authorisation
Decentralised authentication via OpenID, with OAuth 2.0 where an organisational key is required. All data encrypted.
Application programming interface
Synchronous REST/tooling APIs with JSON and XML, plus Bulk API 2.0 (CSV) and Metadata API (XML) for asynchronous work.
Cybersecurity resiliency
Protection against third- and fourth-party risk using SPDX, SLSA and SBOM alongside SSL certification.
Geographic information system
Locating and surveilling AMR patterns alongside pharmacy dispensing, household and farm locations.
Machine-learning processes
Prepared datasets with approaches such as support vector machines and logistic regression.
Excellent user experience
Caching, fast loading, cross-device compatibility and CRM integration.
Competitive edge
- Comprehensive integration with hospital workflows such as EHRs, designed specifically for AMR optimisation
- Public-health surveillance capability for broader AMR tracking with AI-driven metrics
- Real-time predictive analytics and decision support for AMR interventions
- Actionable tools for hospital-based AMR stewardship that are practical in clinical use
- User-friendly dashboards designed for policymakers across different healthcare settings
Market landscape
Leaders
Visionaries
Challengers
Niche players
Porter's five forces
Buyer power
Supplier power
Threat of substitution
Competitive rivalry
Barriers to new entry
Prioritisation (MoSCoW)
Must have
- Minimum viable product / beta concept
- Cloud storage
- Multi-device support
- Updated homepage map
- Updated product features page
Should have
- Multi-factor authentication
- Good UI
- Data back-up solutions
- Sourced testimonials
Could have
- Open app ecosystem
- Single sign-on
- Email newsletter
- Updated support pages
- Case studies
Won't have
- Videos (this iteration)
Commercial model — subscriptions and licences
Access to basic AMR analytics
Small clinics, individual providers, researchers or NGOs with limited budgets
Adds telehealth access
Mid-sized hospitals, regional health organisations and local government health departments
Adds API integration
Large healthcare systems, national governments, pharmaceutical companies and global NGOs
| Package | Price range | Features | Target customers |
|---|---|---|---|
| Standard licence | $50,000–$100,000 | Full dashboard access, real-time AMR data, standard reporting, limited user accounts, regional deployment. | Small-to-mid-sized hospitals, regional providers and NGOs. |
| Premium licence | $150,000–$300,000 | All standard features plus AI-powered analytics, predictive modelling and customisable dashboards. | National healthcare systems, pharmaceutical companies and global NGOs. |
| Enterprise licence | $500,000–$1,000,000+ | Fully customisable software, unlimited users, global deployment and ongoing integration support. | Government health agencies, multinational pharma and global institutions. |
Year one cost breakdown
Broader year one cost
Core dashboard, basic AI analytics and pilot testing.
Compliance, marketing, salaries, infrastructure scaling and 3–5 employees over six months.
Combined MVP and scaling costs.
Year two: scaling and market penetration
Revenue estimate by stream
| Revenue stream | Year 1 | Year 2 | Year 3 | Total |
|---|---|---|---|---|
| Subscription fees | $60,000 | $120,000 | $250,000 | $430,000 |
| Licensing fees | $30,000 | $90,000 | $180,000 | $300,000 |
| Data analytics services | $15,000 | $40,000 | $85,000 | $140,000 |
| API access fees | $8,000 | $25,000 | $60,000 | $93,000 |
| Grants and sponsorships | $25,000 | $50,000 | $80,000 | $155,000 |
| Educational programmes | $10,000 | $25,000 | $50,000 | $85,000 |
| Consulting services | $12,000 | $50,000 | $120,000 | $182,000 |
| Advertising / sponsorships | $5,000 | $20,000 | $40,000 | $65,000 |
| Pay-per-use model | $5,000 | $15,000 | $30,000 | $50,000 |
Total projected revenue across all streams is $1,500,000 over two to three years, or $5,000,000 over five to six years, accounting for scaling, market expansion and service diversification.
Prioritised revenue strategies
Global market expansion
Target AMR hotspots with localised solutions and NGO and government partnerships.
$150,000 est. annual impact
Freemium model with upselling
Attract users with free basic features, then upsell premium tools.
$120,000 est. annual impact
Grants and sponsored research
Apply for multi-year grants from global organisations.
$100,000 est. annual impact
Educational programme scalability
Expand certifications, partner with accreditation bodies and launch online courses.
$50,000 est. annual impact
AI-driven predictive tools as add-ons
Develop AMR forecasting and advanced treatment analytics.
$75,000 est. annual impact
Partnerships and co-branding
Collaborate with diagnostic companies and health insurers.
$60,000 est. annual impact
Consulting services expansion
Advisory services for policy development and hospital accreditation.
$50,000 est. annual impact
API expansion for developers
Monetise EHR integrations and custom AMR solutions.
$40,000 est. annual impact
Ethical advertising and sponsorships
Feature AMR tools and diagnostics on the dashboard ethically.
$20,000 est. annual impact
Profit model
Centralising data for decision and policy makers
Forward propagation, epoch and cross-validation techniques support accessible, shareable data collection and surveillance services.
Providing AI integration services
Investing in data management, streamlining data for product design, delivery and operational improvement.
Offering consulting services
Telehealth consultation with specialists on clinical and non-clinical AMR, including veterinary, poultry and goods, and outbreak investigation during epidemics.
Creating AI-generated content
A private library that seeds further AMR projects and research, acting as an incubator for AI-related health projects.
Recycling data for a better tomorrow
Secured databases let analysts draw multiple conclusions; information can be sought and paid for through one platform.
Procurement cycle
Market analysis
PESTEL and Porter's five forces confirmed the market needs an application that centralises and analyses data in one place.
Determination of needs
Government clients or contractors purchase services based on the social enterprise strategy and its needs.
Setting procurement policies
Departments are approached through a list of potential vendors within corporate social responsibility, using RFI, RFP and RFQ.
Stakeholders' convincement
Investors, finance professionals, providers, contractors, suppliers and customers all participate in the process.
Human capital evaluation
Cost and savings, spending, supply and return on investment sit at the top of the strategy, using TQM with invoicing and three-way matching.
Software procurement implementation
Automation makes procurement faster, less error-prone and more cost-efficient within source-to-pay processes.
Product phases
Phase I: Research & development
Assemble the core development team and build initial partnerships with tech companies and healthcare institutions for pilot testing and MVP launch.
Phase II: Product refinement & scaling
Enhance the platform with advanced AI features and expand server capacity, data analytics and cybersecurity.
Phase III: Growth & brand establishment
Expand to global healthcare systems, attend international health-tech conferences and collaborate with civil society on AMR tracking.
Phase IV: Advanced AI & customisation
Invest in algorithmic accuracy and user-centric features, expand customer support and let customers customise their analytics dashboards.
Phase V: Global expansion
Establish leadership in AMR tech, develop APIs to integrate with EHR/EMR and launch advocacy campaigns.
Phase VI: Sustained innovation
Leverage new technologies such as IoT for live AMR data feeds and build a self-sustaining third-party developer ecosystem.
Business roadmap
Stage 1: Planning
Articulate goals, build the project profile, allocate resources, detail the plan and run situation analysis.
Stage 2: Initiation
Establish the foundation and find stakeholders to support the project logistically, technologically and financially before prototyping, including AMR summits and hackathons.
Stage 3: Partnerships
Cooperate with government, private, public and academic sectors and NGOs to streamline approvals and include them in decision-making.
Stage 4: Design
After stakeholder feedback, refine and iterate, then finalise design specifications and concept development.
Stage 5: Deployment
Pilot technologies and MVPs in three major cities, targeting regions with high AMR impact.
Stage 6: Validation
Evaluate pilot performance, refine technologies and secure initial funding from health organisations, environmental agencies or venture capital.
Stage 7: Publications
Publish findings in peer-reviewed journals and launch public awareness campaigns and educational programmes.
Stage 8: Growth
Expand the project to reach different cities across the Kingdom.
Stage 9: Expansion
Explore monetisation through licensing, partnerships and service-based models.
Stage 10: Market penetration
Develop scalable versions of the technology for broader deployment.
Stage 11: Full deployment
Roll out the solution across a larger geographic or industrial scope.
Stage 12: Monitoring & evaluation
Establish ongoing evaluation mechanisms for long-term effectiveness and innovation.
Stage 13: Legacy & global influence
Solidify thought leadership in AMR, contribute to global policies and host innovation forums.
Twelve-week implementation plan
Weeks 1–2
Requirements gathering to define technical needs and key data points, with the product manager aligning the product to user needs; system design for a scalable backend and dashboard mockups.
Weeks 3–4
concept (MVP) development: core functions built by a full-stack developer and initial data pipelines set up by a data engineer.
Weeks 5–6
Internal MVP testing for bugs, encryption assurance and data-accuracy validation, followed by pilot implementation and user training.
Weeks 7–8
Feedback collection and iteration, refinements by the lead developer, enhanced protection, and AI/IoT integration for predictive analysis and real-time sensor data.
Weeks 9–10
Training and documentation including user manuals; launch planning and final deployment with stakeholder approval of the rollout strategy.
Weeks 11–12
Monitoring and maintenance shared across the team, with feedback loops between stakeholders.
Code of conduct
Value-driven conduct
Adhering to transparency, reproducibility, fairness, solidarity and human dignity in conformity with moral and social values.
Safeguarding autonomous data
High-risk patients are micro-targeted within the purpose limitation of health mapping. Surveillance and research data is never commercialised, capitalised or colonised by any entity.
Promoting accuracy and reliability
Designers ensure AI tasks produce accurate, reliable data delivered effectively to stakeholders, who are involved from the outset to ensure transparency.
Citizen-friendly approach
AI involves the public in research, discussion and tool-building through co-creation across age, culture and geography rather than replacing them.
Organisational focus
Project management and development
Planning projects and teams, aligning phases with timelines, forming partnerships and leading coordination.
Research and training
Data entry and analysis, research ideas, field studies and surveys, seminars, conferences and policy papers.
Technology
Software development from concept to full deployment, data optimisation, documentation and performance metrics.
Operations
Community participation campaigns, protocols, event management and region-specific customisation.
Operational values are simulated. Historical records and source-listed forecasts retain their original attribution; they are not measured GermQ outcomes.